Polyfunctional CD4+and CD8+ T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment

Journal of Immunology

Volumn 184, Issue 11, 2010, Pages 6537-6544

  Sutherland, Jayne S ^a   Young, James M ^a,b   Peterson, Kevin L ^a   Sanneh, Bakary ^a   Whittle, Hilton C ^a   Rowland Jones, Sarah L ^a,c   Adegbola, Richard A ^a,d   Jaye, Assan ^a   Ota, Martin O C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; CELL SEPARATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; TUBERCULOSIS;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS; YOUNG ADULT;

EID: 77953392396     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000399     Document Type: Article

References (31)

1. WHO 2009 TB/HIV Factsheet. Stop TB partnership, p. 1-2. Available at: www.stoptb.org/wg/tb-hiv/factsheets.asp. Accessed: November 17, 2009.
2. Nunn, P., B. Williams, K. Floyd, C. Dye, G. Elzinga, and M. Raviglione. 2005. Tuberculosis control in the era of HIV. Nat. Rev. Immunol. 5: 819-826.
3. Lewinsohn, D. A., A. S. Heinzel, J. M. Gardner, L. Zhu, M. R. Alderson, and D. M. Lewinsohn. 2003. Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am. J. Respir. Crit. Care Med. 168: 1346-1352.
4. Goldsack, L., and J. R. Kirman. 2007. Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb.) 87: 465-473 (Review).
5. Stenger, S. 2005. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann. Rheum. Dis. 64: iv24-28 (Review).
6. Hammond, A. S., S. J. McConkey, P. C. Hill, S. Crozier, M. R. Klein, R. A. Adegbola, S. Rowland-Jones, R. H. Brookes, H. Whittle, and A. Jaye. 2008. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J. Infect. Dis. 197: 295-299.
7. Beveridge, N. E., D. A. Price, J. P. Casazza, A. A. Pathan, C. R. Sander, T. E. Asher, D. R. Ambrozak, M. L. Precopio, P. Scheinberg, N. C. Alder, et al. 2007. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur. J. Immunol. 37: 3089-3100.
8. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
9. Sutherland, J. S., I. M. Adetifa, P. C. Hill, R. A. Adegbola, and M. O. Ota. 2009. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39: 723-729.
10. Talati, N. J., U. Seybold, B. Humphrey, A. Aina, J. Tapia, P. Weinfurter, R. Albalak, and H. M. Blumberg. 2009. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect. Dis. 9: 15.
11. Karam, F., F. Mbow, H. Fletcher, C. S. Senghor, K. D. Coulibaly, A. M. LeFevre, N. F. Ngom Gueye, T. Dieye, P. S. Sow, S. Mboup, and C. Lienhardt. 2008. Sensitivity of IFN-g release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE 3: e1441.
12. Leidl, L., H. Mayanja-Kizza, G. Sotgiu, J. Baseke, M. Ernst, C. Hirsch, D. Goletti, Z. Toossi, and C. Lange. 2010. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur. Respir. J. 35: 619-626.
13. Badri, M., D. Wilson, and R. Wood. 2002. Effect of highly active anti-retroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359: 2059-2064.
14. Lawn, S. D., L. Myer, D. Edwards, L. G. Bekker, and R. Wood. 2009. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23: 1717-1725.
15. Lawn, S. D., R. J. Wilkinson, M. C. Lipman, and R. Wood. 2008. Immune reconstitution and "unmasking" of tuberculosis during anti-retroviral therapy. Am. J. Respir. Crit. Care Med. 177: 680-685.
16. Boom, W. H. 2007. New TB vaccines: is there a requirement for CD8+ T cells? J. Clin. Invest. 117: 2092-2094.
17. Bruns, H., C. Meinken, P. Schauenberg, G. Härter, P. Kern, R. L. Modlin, C. Antoni, and S. Stenger. 2009. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119: 1167-1177.
18. Patel, N. R., J. Zhu, S. D. Tachado, J. Zhang, Z. Wan, J. Saukkonen, and H. Koziel. 2007. HIV impairs TNF-α mediated macrophage apoptotic response to Mycobacterium tuberculosis. J. Immunol. 179: 6973-6980.
19. Bekker, L. G., A. L. Moreira, A. Bergtold, S. Freeman, B. Ryffel, and G. Kaplan. 2000. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 68: 6954-6961.
20. Balcewicz-Sablinska, M. K., J. Keane, H. Kornfeld, and H. G. Remold. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 161: 2636-2641.
21. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
22. Bucy, R. P., R. D. Hockett, C. A. Derdeyn, M. S. Saag, K. Squires, M. Sillers, R. T. Mitsuyasu, and J. M. Kilby. 1999. Initial increase in blood CD4(+) lymphocytes after HIV anti-retroviral therapy reflects redistribution from lymphoid tissues. J. Clin. Invest. 103: 1391-1398.
23. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debré, and J. Leibowitch. 1997. Positive effects of combined anti-retroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116.
24. Wilkinson, K. A., R. Seldon, G. Meintjes, M. X. Rangaka, W. A. Hanekom, G. Maartens, and R. J. Wilkinson. 2009. Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 180: 674-683.
25. Rowland-Jones, S., and T. de Silva. 2008. Resisting immune exhaustion in HIV-1 infection. PLoS Med. 5: e103.
26. Day, C. L., N. Mkhwanazi, S. Reddy, Z. Mncube, M. van der Stok, P. Klenerman, and B. D. Walker. 2008. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J. Infect. Dis. 197: 990-999.
27. Bourgarit, A., G. Carcelain, A. Samri, C. Parizot, M. Lafaurie, S. Abgrall, V. Delcey, E. Vicaut, D. Sereni, and B. Autran; PARADOX Study Group 2009. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J. Immunol. 183: 3915-3923.
28. Meintjes, G., K. A. Wilkinson, M. X. Rangaka, K. Skolimowska, K. van Veen, M. Abrahams, R. Seldon, D. J. Pepper, K. Rebe, P. Mouton, et al. 2008. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 178: 1083-1089.
29. Tabarsi, P., A. S. Saber-Tehrani, P. Baghaei, M. Padyab, D. Mansouri, M. Amiri, M. R. Masjedi, and F. L. Altice. 2009. Early initiation of anti-retroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. J. Int. AIDS Soc. 12: 14.
30. Geretti, A. M., and T. Doyle. 2010. Immunization for HIV-positive individuals. Curr. Opin. Infect. Dis. 23: 32-38.
31. Tena-Coki, N. G., T. J. Scriba, N. Peteni, B. Eley, R. J. Wilkinson, P. Andersen, W. A. Hanekom, and B. Kampmann. 2010. CD4 and CD8 T cell responses to Mycobacterial antigens in African children. Am. J. Respir. Crit. Care Med. (Mar):11 (epub ahead of print).